Presti J Jr - Search Results

1

Presti J Jr, Alexeeff S, Avins AL. Presti J Jr, et al. N Engl J Med. 2023 Jul 6;389(1):93-94. doi: 10.1056/NEJMc2305651. N Engl J Med. 2023. PMID: 37407016 No abstract available.

2

Reply by Authors.

Horton B, Alexeeff S, Prausnitz S, Avins AL, Presti J Jr. Horton B, et al. Among authors: presti j jr. Urol Pract. 2022 Jan;9(1):71. doi: 10.1097/UPJ.0000000000000274.02. Epub 2021 Dec 2. Urol Pract. 2022. PMID: 37145589 No abstract available.

3

Race-Specific Trends in Prostate Cancer Screening and Presentation before and after the 2012 United States Preventive Services Task Force Statement.

Horton B, Alexeeff S, Prausnitz S, Avins AL, Presti J Jr. Horton B, et al. Among authors: presti j jr. Urol Pract. 2022 Jan;9(1):64-71. doi: 10.1097/UPJ.0000000000000274. Epub 2021 Dec 2. Urol Pract. 2022. PMID: 37145559

4

Impact of 2012 Prostate Cancer Screening Statement.

Presti J Jr, Alexeeff S, Avins AL. Presti J Jr, et al. J Gen Intern Med. 2021 Sep;36(9):2854-2855. doi: 10.1007/s11606-021-06996-y. Epub 2021 Jul 13. J Gen Intern Med. 2021. PMID: 34258729 Free PMC article. No abstract available.

5

Changing Provider PSA Screening Behavior Using Best Practice Advisories: Interventional Study in a Multispecialty Group Practice.

Presti J Jr, Alexeeff S, Horton B, Prausnitz S, Avins AL. Presti J Jr, et al. J Gen Intern Med. 2020 Nov;35(Suppl 2):796-801. doi: 10.1007/s11606-020-06097-2. Epub 2020 Oct 26. J Gen Intern Med. 2020. PMID: 33107000 Free PMC article.

6

Prospective development of a prostate cancer risk calculator in a racially diverse population: The Kaiser Permanente Prostate Cancer Risk Calculator.

Presti J Jr,, Alexeeff S, Horton B, Prausnitz S, Avins AL. Presti J Jr,, et al. Urol Oncol. 2020 Nov;38(11):847.e1-847.e8. doi: 10.1016/j.urolonc.2020.05.011. Epub 2020 Jun 12. Urol Oncol. 2020. PMID: 32536468

7

Changes in Prostate Cancer Presentation Following the 2012 USPSTF Screening Statement: Observational Study in a Multispecialty Group Practice.

Presti J Jr, Alexeeff S, Horton B, Prausnitz S, Avins AL. Presti J Jr, et al. J Gen Intern Med. 2020 May;35(5):1368-1374. doi: 10.1007/s11606-019-05561-y. Epub 2019 Dec 9. J Gen Intern Med. 2020. PMID: 31820217 Free PMC article.

8

High serum folate is associated with reduced biochemical recurrence after radical prostatectomy: results from the SEARCH Database.

Moreira DM, Bañez LL, Presti JC Jr, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ. Moreira DM, et al. Among authors: presti jc jr. Int Braz J Urol. 2013 May-Jun;39(3):312-8; discussion 319. doi: 10.1590/S1677-5538.IBJU.2013.03.03. Int Braz J Urol. 2013. PMID: 23849564 Free article.

9

Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR? A report from the SEARCH database group.

Teeter AE, Presti JC Jr, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ. Teeter AE, et al. Among authors: presti jc jr. Urology. 2013 Jul;82(1):53-8. doi: 10.1016/j.urology.2012.10.090. Urology. 2013. PMID: 23806388 Free PMC article.

10

Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy.

Punnen S, Freedland SJ, Presti JC Jr, Aronson WJ, Terris MK, Kane CJ, Amling CL, Carroll PR, Cooperberg MR. Punnen S, et al. Among authors: presti jc jr. Eur Urol. 2014 Jun;65(6):1171-7. doi: 10.1016/j.eururo.2013.03.058. Epub 2013 Apr 8. Eur Urol. 2014. PMID: 23587869

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

186 results

Search Page